UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
|
For the month of: February 2012 |
Commission File Number: 001-33526 |
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
(Name of Registrant)
225 Promende du Centropolis
Suite 200
Laval, Québec
Canada H7T 0B3
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
Form 20-F [ ]
|
Form 40-F [X]
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes [ ]
|
No [X]
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
|
||
| Date: February 6, 2012 | By: | /s/ Henri Harland |
| Name: | Henri Harland | |
| Title: | President and Chief Executive Officer | |
EXHIBIT INDEX
|
Exhibit |
Description of Exhibit |
| 99.1 | News Release dated February 2, 2012 |